The Effects of RPL554 on Top of Standard COPD Reliever Medications
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
- DRUG: Salbutamol
- DRUG: Ipratropium
- DRUG: RPL554
- DRUG: Salbutamol matched placebo
- DRUG: Ipratropium matched placebo
- DRUG: RPL554 matched placebo
Sponsor
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA